Drugs

Scientists find potential new drug target to prevent Ebola

Read more

AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

Read more

Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline

Read more

IPC issues alert against adverse reactions of painkiller Meftal

Read more

Pfizer to price COVID treatment Paxlovid at $1,390 per course

Read more

Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets

Read more

Enzene Biosciences launches Bevacizumab

Read more

Prices of 103 formulation packs to come down after NPPA cap

Read more

DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?

Read more

NPPA seeks to recover Rs 4,551 crore for overcharging

Read more